Ohio State, Ohio University pool resources to address start-up funding

Brutus Buckeye and Rufus the Bobcat did not attend the announcement

The Ohio State University and Ohio University are partnering to create a new commercialization and funding model. They have committed $35 million in total to the formation of a venture capital fund designed to meet early-stage funding needs of innovative technology ventures.

Ohio State’s commitment to the fund is $20 million and Ohio University has pledged $15 million. The universities also will leverage their resources and assets to bring the best talent, funding and facilities to accelerate entrepreneurial activity and venture creation in Ohio.

“Universities, with our depth of research expertise, creative faculty, business capabilities and eager, well-prepared students, are uniquely positioned to help innovative companies grow and succeed,” said Ohio State President E. Gordon Gee. “We are honored to be partnering with Ohio University to enhance the state’s commercialization ecosystem, building a stronger environment in which to grow our economy.”

“We believe we have identified a new model for technology commercialization success,” said Ohio University President Roderick J. McDavis. “Taking what we have learned on an institutional level and applying it on a larger scale has great potential for our state, our students, faculty, staff, and most importantly, all Ohioans.”

Both institutions are BioOhio Founding Members and boast world-class biomedical research capabilities. It is safe to assume medical and health-related innovations will garner significant attention from the newly created fund.

Get more details in news releases from OSU and OU.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Porter Wright getting new managing partner, Bob Tannous will take over for Robert Trafford | Columbus Business First, October 22, 2014

Cardinal Health donates one million medical products to help fight Ebola in West Africa | The Columbus Dispatch, October 21, 2014

Procter & Gamble hiring soon for distribution center in Union’s Global Logistics Airpark | WDTN2 News, October 21, 2014

Central Ohio career technical education partnerships are shaping tomorrow’s workforce today | Columbus CEO, October 21, 2014

NanoLogix developing rapid test for Ebola virus (video) | WYTV33 Youngstown, October 21, 2014

Analytic, a partnership of Anatrace and Microlytic: enabling membrane protein research | PR Web, October 21, 2014

Quasar Energy Group uses organic waste to produce renewable energy | Todays Energy Solutions, October 21, 2014

Frank Samuel, President of VentureOhio and former BioOhio President dies in auto accident | Geauga County Maple Leaf, October 21, 2014

Milo Biotechnology’s follistatin gene therapy increases function in Becker Muscular Dystrophy patients | PR Newswire, October 20, 2014

Skilled Care Pharmacy and Assurex Health announce partnership to provide GeneSight genetic test | Assurex Health, October 20, 2014

Mayo Clinic and Cleveland Clinic latest to deploy HealthSpot telemedicine booths | Columbus Business First, October 20, 2014

OSU Wexner Medical Center study: new implantable device to control heart failure shows promising results | Todays Medical Developments, October 17, 2014

Assurex Health gets $6M funding for clinical trial related to patients with depression or schizophrenia | Cincinnati Business Courier, October 17, 2014

University of Cincinnati lands grant to attack hepatitis C among needle users in 20 counties | WCPO9 Cincinnati, October 16, 2014

Control Bionics interview, developing technology that enables individuals with debilitating conditions to communicate | The Clermont Sun, October 16, 2014

BioOhio member Oralectrics spinout Zumby opens crowdfunding campaign | Cleveland.com, October 16, 2014

Ohio State sophomore Peeyush Shrivastava of Genetesis named a finalist in $5M 43North business plan competition | Columbus Business First, October 16, 2014

Navidea hires Rick Gonzalez as CEO from Spectrum Pharmaceuticals, replaces Michael Goldberg, Navidea’s lead investor | Columbus Business First, October 15, 2014

Health Care DataWorks’ Chief Data Scientist to present at healthcare conference sponsored by HIMSS Georgia Chapter | PR Web, October 15, 2014

FDA approves expanded use of Navidea’s Lymphoseek for lymphatic mapping in solid tumors | Business Wire, October 15, 2014